An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Consideration for Use of Novel Agents in Acute Myeloid Leukemia 0.55 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Optimizing the Care of Patients Receiving CAR T-Cell Therapy 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Emerging Options for the Management of Relapsed/Refractory Hodgkin Lymphoma 0.54 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms 0.75 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Keynote Session: CAR T-cell Therapy - Historical Perspectives and Major Milestones 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Patient Case Studies and Panel Discussion: Lymphoma 1.00 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Patient Case Studies and Panel Discussion: Leukemia and Myeloproliferative Neoplasms 1.00 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Management of Toxicities Associated with Immune Checkpoint Inhibitors 0.40 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Optimizing Small Molecule Inhibitor Therapy for Relapsed/Refractory B-cell Lymphomas 1.00 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Current Approaches to Initial Treatment of Newly Diagnosed Multiple Myeloma 0.52 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Keynote Session: CAR T-cell Therapy - Focus on Lymphomas 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Updates in the Management of CLL: Histologic Transformation and Relapsed/Refractory Disease 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Non-Small Cell Lung Cancer 0.75 11/07/2018 - 12:00am to 11/07/2019 - 12:00am
NCCN Guidelines® Insights - Cancer-Associated Venous Thromboembolic Disease, Version 2.2018 1.00 11/10/2018 - 12:00am to 11/10/2019 - 12:00am
Recorded Presentation from the NCCN Pharmacy Updates: Safe Handling of Chemotherapy 0.75 11/20/2018 - 12:00am to 11/20/2019 - 12:00am

Pages